HOME >> BIOLOGY >> NEWS
New x-ray resource for examining biomolecular structures

Bethesda, MDThe National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), announced today an agreement between the Argonne National Laboratory's Advanced Photon Source (APS) and the NCRR-supported Northeastern Collaborative Access Team, or NE-CAT, to build three experimental stations, known as beamlines, at the APS for synchrotron radiation research.

These beamlines will harness the brilliant X-rays generated at the APS and apply them to the study of protein complexes and other biomolecular structures. Detailed understanding of molecular shapes and interactions has allowed scientists to devise improved therapies for diseases ranging from AIDS to the flu.

Synchrotron X-rays have an incomparable ability to reveal the three-dimensional structures of biological molecules at high resolution. Therefore, access to synchrotron research facilities is in great demand by the biomedical research community. Currently synchrotron radiation can be generated at fewer than a dozen facilities in the United States. Of the 40 beamlines operational in the United States, NCRR supports 24not including the new NE-CAT stationsfor use by NIH-supported investigators and other biomedical researchers.

"NE-CAT will provide biomedical scientists with urgently needed access to synchrotron radiation, which is an unsurpassed tool for probing biomolecular structures" says NCRR Director Dr. Judith L. Vaitukaitis. "Information from detailed structural studies will lead us toward an understanding of how proteins function and interact and will, in some cases, be the basis for designing new therapeutics for human disease."

The NE-CAT research team comprises faculty from six academic institutions: Cornell University, Columbia University, Harvard University, Memorial Sloan-Kettering Cancer Center, Rockefeller University and Yale University. The NE-CAT director is Dr. Stephen E. Ealick, professor of chemistry and chemical biology
'"/>

Contact: Kathy Kaplan
kaplank@ncrr.nih.gov
301-435-0888
NIH/National Center for Research Resources
1-May-2002


Page: 1 2

Related biology news :

1. Bay area to get unique x-ray microscopy resource
2. Scientists harness powerful x-rays in new technique to study animal functions
3. New x-ray technique images cartilage, may lead to earlier diagnosis of osteoarthritis
4. Scientists capture first images of how x-rays damage proteins
5. Report in Science on x-ray crystal structure of matrix Metalloproteinase-2 (MMP-2)
6. New Arizona State center brings science to policy on issues of water resources and urban growth
7. Posters highlight water, energy and other natural resource research
8. Tufts University establishes $4 million dollar tissue engineering resource center
9. Nerac to expand patent collection with 17 more resources
10. Fair to showcase innovations in natural resources, forestry
11. Plant pathologists express need for plant pathology-related microbial culture resources

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New ray resource for examining biomolecular structures

(Date:3/20/2015)... 20, 2015 Research and Markets ... the "India Sensors Market Forecast and Opportunities ... The sensor market is projected to grow at ... Consumer electronics, automotive, industrial and healthcare sectors are ... country. In addition, adoption of MEMS technology in ...
(Date:3/20/2015)... Conn. , March 20, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... smart wallet is one of the products featured in ... March 20th at 11:00 PM EST on the DIY ... to Las Vegas , site of ...
(Date:3/19/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... week on Washington DC,s Fox 5 ... "The Next Great Thing", host Laura Evans calls ... ,a really big breakthrough in mobile payment.,  ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3
(Date:4/16/2015)... MOSCOW , April 16, 2015 /PRNewswire/ ... (ChemRar), the Russian pharmaceutical investment and R&D ... announced collaboration for research, development and commercialization ... with the intention to stimulate ... industry.      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     ...
(Date:4/16/2015)... , April 16, 2015  AnaptysBio, Inc., a ... therapeutic antibodies, today announced the advancement of ... into IND-enabling studies. The Company,s anti-IL-36R therapeutic ... for generalized pustular psoriasis (GPP), an orphan ... need. ANB019 is wholly owned within AnaptysBio,s proprietary ...
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, an ... improving cancer surgeries, announced today that it has initiated ... illuminator, AVB-620, in women with primary, non-recurrent breast cancer ... also welcomed the addition of Steven Chen , ... The open label, dose escalation study will enroll up ...
(Date:4/16/2015)... LAUSANNE , Switzerland ... Debiopharm International SA (Debiopharm), part of Debiopharm Group ™ ... prescription drugs that target unmet medical needs ... that preclinical data on the investigational compounds ... inhibitor) will be presented at the 2015 ...
Breaking Biology Technology:Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: